Publication | Open Access
Higher-Dose Primaquine to Prevent Relapse of <i>Plasmodium vivax</i> Malaria
39
Citations
21
References
2022
Year
The administration of primaquine at a total dose of 7.0 mg per kilogram had higher efficacy in preventing relapse of <i>P. vivax</i> malaria than a total dose of 3.5 mg per kilogram through day 168. (Supported by the U.S. Agency for International Development; ClinicalTrials.gov number, NCT03610399.).
| Year | Citations | |
|---|---|---|
Page 1
Page 1